Moreover, their levels were relevant also for patient survival, since all these populations correlated with a longer survival except for CD4+ T cells, confirming the primary role of CD137+ T cells, particularly the CD8+ subset in the induction of the anti-tumor immune response. Here, TNFRSF9 is linked to neoplasm.